New: the Income Securities Screening Form now screens by price, yield, S&P rating, call status and trading volume, and you can save your searches to run again. Try the updated form.
Beta Bionics, Inc (BBNX)
BBNX · NGM · Common · CUSIP 08659B102
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for BBNX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
08659B102
IPO
1/30/2025 · 12 Million Shares @ $18.00/share
Prospectus
Preliminary IPO prospectus »
Business: Beta Bionics, Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of innovative solutions by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of insulin-requiring people with diabetes.

Company Contact

CEO
Sean Saint
CFO
Stephen Feider
Headquarters
11 Hughes, Irvine, CA 92618
Phone
949-427-7785
Investor Relations
Blake Beber · 949-427-7785 · ir@betabionics.com
SEC EDGAR Filings
View filings »